nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Respiratory distress—Metformin—polycystic ovary syndrome	0.0189	0.119	CcSEcCtD
Nalbuphine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00784	0.0494	CcSEcCtD
Nalbuphine—Sweating increased—Metformin—polycystic ovary syndrome	0.00733	0.0462	CcSEcCtD
Nalbuphine—Bradycardia—Metformin—polycystic ovary syndrome	0.00613	0.0386	CcSEcCtD
Nalbuphine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00599	0.0377	CcSEcCtD
Nalbuphine—Flushing—Metformin—polycystic ovary syndrome	0.00559	0.0352	CcSEcCtD
Nalbuphine—Erythema—Metformin—polycystic ovary syndrome	0.00524	0.033	CcSEcCtD
Nalbuphine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00513	0.0323	CcSEcCtD
Nalbuphine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00504	0.0317	CcSEcCtD
Nalbuphine—Vision blurred—Metformin—polycystic ovary syndrome	0.00494	0.0311	CcSEcCtD
Nalbuphine—Tremor—Metformin—polycystic ovary syndrome	0.00491	0.0309	CcSEcCtD
Nalbuphine—Syncope—Metformin—polycystic ovary syndrome	0.0047	0.0296	CcSEcCtD
Nalbuphine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00461	0.029	CcSEcCtD
Nalbuphine—Hypertension—Metformin—polycystic ovary syndrome	0.00452	0.0285	CcSEcCtD
Nalbuphine—Oedema—Metformin—polycystic ovary syndrome	0.00428	0.0269	CcSEcCtD
Nalbuphine—Shock—Metformin—polycystic ovary syndrome	0.00421	0.0265	CcSEcCtD
Nalbuphine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00413	0.026	CcSEcCtD
Nalbuphine—Hypotension—Metformin—polycystic ovary syndrome	0.004	0.0252	CcSEcCtD
Nalbuphine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00384	0.0242	CcSEcCtD
Nalbuphine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00381	0.024	CcSEcCtD
Nalbuphine—Somnolence—Metformin—polycystic ovary syndrome	0.0038	0.024	CcSEcCtD
Nalbuphine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00376	0.0237	CcSEcCtD
Nalbuphine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00352	0.0222	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0035	0.022	CcSEcCtD
Nalbuphine—Urticaria—Metformin—polycystic ovary syndrome	0.0034	0.0214	CcSEcCtD
Nalbuphine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00338	0.0213	CcSEcCtD
Nalbuphine—Asthenia—Metformin—polycystic ovary syndrome	0.00307	0.0193	CcSEcCtD
Nalbuphine—Pruritus—Metformin—polycystic ovary syndrome	0.00303	0.0191	CcSEcCtD
Nalbuphine—Dizziness—Metformin—polycystic ovary syndrome	0.00283	0.0178	CcSEcCtD
Nalbuphine—Vomiting—Metformin—polycystic ovary syndrome	0.00272	0.0171	CcSEcCtD
Nalbuphine—Rash—Metformin—polycystic ovary syndrome	0.0027	0.017	CcSEcCtD
Nalbuphine—Dermatitis—Metformin—polycystic ovary syndrome	0.00269	0.017	CcSEcCtD
Nalbuphine—Headache—Metformin—polycystic ovary syndrome	0.00268	0.0169	CcSEcCtD
Nalbuphine—Nausea—Metformin—polycystic ovary syndrome	0.00254	0.016	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00154	0.00183	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00153	0.00181	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00148	0.00176	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00148	0.00176	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00148	0.00176	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00147	0.00175	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00146	0.00174	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00145	0.00173	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00144	0.00171	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00144	0.00171	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00142	0.00169	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00142	0.00169	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00141	0.00168	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00141	0.00168	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00141	0.00167	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.0014	0.00167	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.0014	0.00166	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00139	0.00165	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00137	0.00163	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00136	0.00161	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00134	0.0016	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00134	0.00159	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00132	0.00157	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00131	0.00156	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00131	0.00156	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00131	0.00156	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00129	0.00154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00129	0.00153	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00128	0.00152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00128	0.00152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00127	0.00151	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00126	0.00149	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00125	0.00149	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00124	0.00148	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00124	0.00148	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00124	0.00147	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00123	0.00146	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00123	0.00146	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00123	0.00146	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00121	0.00144	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.0012	0.00143	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.0012	0.00143	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00119	0.00142	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00119	0.00142	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00119	0.00141	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00119	0.00141	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00118	0.0014	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00118	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00117	0.00139	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00115	0.00137	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00114	0.00135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00113	0.00134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00112	0.00133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00112	0.00133	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00111	0.00132	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.0011	0.00131	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.0011	0.00131	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.0011	0.00131	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00109	0.0013	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00109	0.0013	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00108	0.00129	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00107	0.00127	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00105	0.00125	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00105	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00105	0.00124	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00104	0.00124	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00104	0.00123	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00104	0.00123	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00104	0.00123	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00104	0.00123	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00102	0.00121	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00102	0.00121	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.001	0.00119	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000998	0.00119	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000992	0.00118	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000974	0.00116	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000973	0.00116	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL6—polycystic ovary syndrome	0.00097	0.00115	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000968	0.00115	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000954	0.00113	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000949	0.00113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000948	0.00113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000943	0.00112	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00094	0.00112	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000931	0.00111	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000928	0.0011	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000925	0.0011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000922	0.0011	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000914	0.00109	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000891	0.00106	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000884	0.00105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000875	0.00104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000875	0.00104	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000864	0.00103	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000846	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000843	0.001	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00084	0.000999	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000832	0.000989	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000823	0.000979	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000818	0.000973	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000812	0.000966	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000811	0.000964	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000795	0.000944	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00079	0.000939	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000773	0.000919	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FST—polycystic ovary syndrome	0.00077	0.000916	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000766	0.00091	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000761	0.000904	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000758	0.000901	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000753	0.000895	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000752	0.000894	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000742	0.000882	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000737	0.000876	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000735	0.000873	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000712	0.000847	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000712	0.000846	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00071	0.000844	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000704	0.000837	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000703	0.000836	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000695	0.000827	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000693	0.000824	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000686	0.000815	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.000675	0.000803	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000672	0.000799	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000672	0.000798	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000667	0.000793	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00066	0.000785	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000659	0.000784	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000655	0.000778	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000645	0.000767	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000644	0.000766	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00064	0.000761	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000627	0.000745	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000624	0.000742	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000623	0.00074	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000623	0.00074	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000618	0.000734	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000611	0.000727	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00061	0.000725	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000603	0.000717	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000602	0.000716	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000589	0.0007	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000586	0.000696	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000579	0.000688	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000577	0.000685	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000574	0.000683	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000571	0.000678	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000568	0.000675	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000565	0.000672	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000564	0.00067	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000557	0.000662	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000548	0.000651	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000545	0.000647	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000539	0.000641	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000536	0.000637	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000534	0.000635	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000529	0.000629	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000527	0.000627	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000526	0.000626	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000522	0.000621	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000515	0.000613	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000506	0.000601	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000498	0.000592	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000496	0.00059	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000496	0.00059	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000489	0.000582	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000485	0.000577	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00048	0.000571	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000478	0.000568	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000478	0.000568	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000473	0.000563	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000473	0.000562	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000468	0.000556	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000462	0.000549	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00046	0.000546	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000453	0.000539	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000447	0.000531	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000437	0.000519	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000435	0.000517	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000435	0.000517	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000434	0.000516	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000433	0.000515	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000427	0.000508	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000419	0.000498	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000417	0.000496	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000415	0.000494	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000411	0.000488	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000406	0.000483	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000405	0.000481	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000403	0.000479	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.0004	0.000475	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000396	0.00047	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000383	0.000455	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000381	0.000453	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000381	0.000453	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00038	0.000451	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000368	0.000437	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000368	0.000437	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000366	0.000435	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000363	0.000431	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00036	0.000428	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000356	0.000423	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000354	0.000421	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000351	0.000417	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000342	0.000407	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000341	0.000405	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000334	0.000397	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000324	0.000385	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000322	0.000382	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000321	0.000381	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000318	0.000378	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000312	0.000371	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000309	0.000368	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000305	0.000363	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000304	0.000362	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000299	0.000355	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000282	0.000336	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000269	0.00032	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000268	0.000318	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000266	0.000317	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000264	0.000314	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000262	0.000311	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000257	0.000305	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000255	0.000303	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000247	0.000293	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000247	0.000293	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000234	0.000279	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000234	0.000278	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000226	0.000269	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000225	0.000267	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	0.000224	0.000266	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000221	0.000263	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000216	0.000257	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000216	0.000257	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000205	0.000244	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000197	0.000235	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.00019	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000189	0.000225	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000189	0.000224	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000183	0.000217	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000183	0.000217	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000174	0.000206	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000165	0.000197	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000161	0.000192	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000141	0.000168	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.00014	0.000166	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000119	0.000142	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000111	0.000132	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	9.77e-05	0.000116	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	8.26e-05	9.82e-05	CbGpPWpGaD
